mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.1 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.1 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.1 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.066 |
0.1 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.1 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.1 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.2 |